KB
Karthik Bokkala
Sreenidhi Institute of Science & Technology
Research areas: Chemistry · Organic Chemistry · Synthesis and biological activity · Synthesis and Characterization of Heterocyclic Compounds · Click Chemistry and Applications
0009-0000-6559-1444
Employment
-
Sreenidhi Institute of Science & Technology2014 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (11)
- Copper(I)-Catalyzed Synthesis of Thiazole-piperazine-1,2,3-triazole Conjugates As In Vitro EGFR Inhibitors and Some In Silico Studies Save
- Design and Synthesis of Some New Indole-piperazine-1,2,3-triazole Conjugates; In Vitro Anticancer, Molecular Docking, and ADMET Studies Save
- New quinoxaline‐piperazine‐oxazole conjugates: Synthesis, in vitro anticancer, in silico ADMET, and molecular docking studies Save
- Synthesis of Some New Coumarin-thiazolidine-2,4-dione-1,2,3-triazole Hybrids as Tubulin Targeting Anti-Lung Cancer Agents Save
- Synthesis of Fused Isoxazoles of Iodoquinol as in vitro EGFR Aiming Anticancer Agents Save
- Design and Synthesis of Some New Benzimidazole-1,2,3-triazole-thiazolidine-2,4-dione Conjugates as Tubulin Polymerization Inhibitors Save
- Synthesis of Fused 1,2,3-Triazoles of Benzimidazole Using Copper (I) Catalysis; in Vitro and in Silico Studies Save
- Synthesis of Some New Barbituric Acid Linked Quinoline-1,2,3-triazole Hybrids as Dual EGFR/VEGFR-2 Inhibitors Save
- Ring‐B Modification of Combretastatin A‐4 to Generate Thiazolidine‐2,4‐dione‐1,2,3‐triazole Hybrids as Tubulin Polymerization Inhibitors Save
- Synthesis of Quinoline‐Morpholine‐Coupled 1,2,3‐Triazole Hybrids as In vitro EGFR inhibitors Save
- One-Pot Regioselective Synthesis of 7-Bromo-2H-Benzo[b][1,4]Oxazin-3(4H)-One Linked Isoxazole Hybrids as Anti-Cancer Agents and Their Molecular Docking Studies Save